APA (7th ed.) Citation

Tian, M., Wei, J. S., Shivaprasad, N., Highfill, S. L., Gryder, B. E., Milewski, D., . . . Khan, J. (2023). Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma. Cell reports. Medicine, 4(10), 101212. https://doi.org/10.1016/j.xcrm.2023.101212

Chicago Style (17th ed.) Citation

Tian, Meijie, et al. "Preclinical Development of a Chimeric Antigen Receptor T cell Therapy Targeting FGFR4 in Rhabdomyosarcoma." Cell Reports. Medicine 4, no. 10 (2023): 101212. https://doi.org/10.1016/j.xcrm.2023.101212.

MLA (9th ed.) Citation

Tian, Meijie, et al. "Preclinical Development of a Chimeric Antigen Receptor T cell Therapy Targeting FGFR4 in Rhabdomyosarcoma." Cell Reports. Medicine, vol. 4, no. 10, 2023, p. 101212, https://doi.org/10.1016/j.xcrm.2023.101212.